A life science company wind-down is a race against multiple simultaneous obligations: notifying employees, managing investor communications, fulfilling regulatory filings, and liquidating physical assets to maximize creditor recovery — all within a timeline set by cash runway, lease terms, or court deadlines. The physical asset disposition component is routinely underestimated until it becomes a crisis.
The Wind-Down Asset Challenge
Life science companies carry asset profiles that are both valuable and complex. A Series B-funded biotech might have $2–8 million in laboratory instruments, -80°C freezers full of biological materials requiring specific handling, controlled substance inventories, proprietary equipment configurations, and infrastructure assets like fume hoods and gas distribution systems that are difficult to separate from the facility.
In a wind-down, all of this must be inventoried, cleared of any regulatory obligations, and disposed of — in the correct sequence, within the lease timeline, and with complete documentation for accounting and legal records. The stakes are high: improper handling of biological materials or controlled substances creates liability. Equipment left in the facility past lease expiration gets billed to the company (or personally to officers, in some structures).
Creditor Recovery Considerations
In a wind-down with creditors, the physical assets represent a pool of recovery capital that boards and creditor committees have a fiduciary obligation to maximize. This means documenting every asset at fair market value at the time of disposition, ensuring that disposal decisions are commercially reasonable, and maintaining records that can withstand scrutiny in a later creditor dispute or legal proceeding.
Assignment for the Benefit of Creditors (ABC) and receivership structures add additional complexity: the assignee or receiver takes legal control of assets and must dispose of them in a commercially reasonable manner that maximizes recovery for the creditor pool. An experienced disposition partner who understands these legal constraints — and can move quickly within them — is essential.
Sequencing the Disposition
Wind-down dispositions must be sequenced around biological material handling first. Biological samples in cold storage require specific decommissioning protocols — transfer to an authorized facility, destruction under witnessed conditions, or return to collaborators. This step often takes 2–4 weeks and must be completed before the storage equipment can be disposed of.
Controlled substance-handling equipment (HPLC systems, balances, and other instruments used in DEA-scheduled substance work) may require DEA coordination before transfer of ownership. Starting this process early is critical; DEA administrative timelines are not negotiable.
After compliance clearances, the disposition sequence follows asset value: high-value instruments go to market immediately, process equipment and furniture follow, and facility infrastructure (installed equipment, utility systems) is handled last in coordination with the landlord's restoration requirements.
Timelines and Pressure Points
The most dangerous assumption in a life science wind-down is that equipment will sell in time to cover lease obligations. Equipment disposition takes time: inventory, photography, listing, auction window, buyer payment, removal coordination, and physical removal. A full facility with $3M in equipment realistically takes 60–90 days to execute well — longer if compliance clearances are involved.
Companies that start the disposition process the day they announce wind-down are already behind. The teams that execute cleanly started disposition planning 30–60 days before the public announcement, during the period when internal decisions were being made. This isn't ethically complex — planning is not the same as disposing; it simply ensures that when the process starts, it starts correctly.
A well-managed wind-down disposition protects creditor recovery, satisfies regulatory obligations, and avoids the lease overrun and liability costs that haunt poorly managed closures. Engaging a specialized disposition partner at the earliest possible moment — even before wind-down is announced — gives you the planning head start that makes a material difference in outcome.